Did anyone actually read this announcement , nothing has been proven from this HIV-1 phase 2 trial , there is only a possibility of an immune effect. Explains why no Pharma is putting up any money up for a phase 3 trial.
"BIT225’s immune modulating effects MAY have utility in improving HIV-1 induced chronic immune activation outcomes and aid in future eradication strategies."
Definition of May
You use MAY to indicate something will possibly happen or be true in the future , but you cannot be certain , vagueness.
- Forums
- ASX - By Stock
- Ann: BIT225 RESTORES IMMUNE FUNCTION IN HIV-1 INFECTIONS
Did anyone actually read this announcement , nothing has been...
-
- There are more pages in this discussion • 96 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.9¢ |
Change
0.001(5.56%) |
Mkt cap ! $17.14M |
Open | High | Low | Value | Volume |
1.8¢ | 1.9¢ | 1.8¢ | $3.69K | 197.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 2175000 | 1.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.9¢ | 480522 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 2175000 | 0.017 |
11 | 2337904 | 0.016 |
16 | 2996688 | 0.015 |
7 | 5758433 | 0.014 |
5 | 1849000 | 0.013 |
Price($) | Vol. | No. |
---|---|---|
0.019 | 480522 | 6 |
0.020 | 1094211 | 7 |
0.021 | 600000 | 1 |
0.022 | 340866 | 2 |
0.023 | 508000 | 2 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online